An industry for healthy lives

Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region.


In hac habitasse platea dictumst. Etiam tempus vehicula nunc in malesuada. Donec tristique consectetur sapien non convallis. Donec posuere fringilla ligula, non tempor mi pretium quis. Ut suscipit pulvinar velit; sit amet viverra risus tincidunt eu. Cras iaculis sodales ante vel consequat. Praesent non erat nec nibh fermentum imperdiet. Nulla vitae interdum arcu. Vestibulum egestas velit tristique augue faucibus euismod. Vivamus justo est, ultrices in accumsan ac, adipiscing sit amet orci? Maecenas lorem nunc, accumsan ut hendrerit sed, iaculis vel dolor. Maecenas gravida nunc nunc.

VE Paper: Proposal for an EU Joint Action on Vaccination

2016 01 22 Written by Vaccines Europe

With the changing demographic structure of the EU population and the rising threats of emerging medical needs such as antimicrobial resistance and healthcare associated infections, there is a fundamental need to define mechanisms capable of prioritising and advising on innovative vaccines needed to protect public health.

The impact of a Joint Action and collaboration at EU level should be to foster innovation for a social purpose at least on three levels:

I. Better prevention and health outcomes from diseases that can be avoided;
II. Sustainable healthcare systems and freeing of resources for medical innovation; and
III. Sustained research and industry investment in the interest of public health needs as to ensure the sustainability of immunisation programmes.

Please find the Vaccines Europe Proposal for an EU Joint Action on Vaccination here.